A federal judge has dismissed one of four pending civil lawsuits against HaloMD, a Texas-based company that represents providers in No Surprises Act arbitration disputes. The ruling marks a significant legal victory for HaloMD. It also raises important questions about how the federal arbitration process operates — and who benefits.
What Happened in Court
The judge granted HaloMD’s motion to dismiss the case brought by Anthem Blue Cross of California. The court found that Anthem failed to establish any legal basis for invalidating the arbitration awards HaloMD had won on behalf of its provider clients.
Key Details of the Ruling
This outcome is notable for several reasons. First, it clears one of the four major legal challenges HaloMD currently faces. Second, it reinforces the company’s argument that its arbitration activity falls within the bounds of the No Surprises Act. Third, it signals that federal courts may be reluctant to reverse arbitration outcomes without a clear statutory basis.
The decision does not end all litigation against HaloMD. However, it does demonstrate that at least one federal court has found the insurer’s case insufficient on its face.
Why Anthem Filed the Lawsuit
Anthem Blue Cross of California filed the suit as part of a broader push by Blue Cross Blue Shield plans to challenge HaloMD’s rapid growth in the arbitration space. Anthem alleged that many of the disputes HaloMD submitted were not actually eligible for arbitration under the No Surprises Act.
The Core Allegation
The No Surprises Act, which took effect in 2022, was designed to protect patients from unexpected out-of-network medical bills. Under the law, insurers and providers who cannot agree on a payment rate can submit the dispute to an independent arbitrator.
Anthem argued that HaloMD exploited this process. According to the insurer, providers working with HaloMD sent large volumes of claims to arbitration — including claims that may not have met the law’s eligibility requirements. The goal, Anthem contended, was to extract higher payments from insurers than providers would have received before surprise billing rules existed.
The judge disagreed with this framing. The ruling found that Anthem did not provide sufficient legal grounds to void HaloMD’s arbitration results.
HaloMD’s Rise in No Surprises Act Arbitration
HaloMD’s growth in this space has been remarkable. In the first half of 2025, the company became the single largest user of the federal No Surprises Act arbitration process. This rapid rise drew scrutiny from insurers, policymakers, and reporters alike.
A Texas-Based Middleman
HaloMD operates as an intermediary — connecting healthcare providers with the arbitration system and managing disputes on their behalf. Critics argue this business model creates incentives to file high volumes of cases, including disputes that may not meet federal eligibility standards. Supporters counter that providers deserve strong representation in a process where insurers hold significant leverage.
The company’s success in arbitration has been financially significant. Providers who win arbitration cases generally receive payments higher than the insurer’s initial offer — sometimes substantially so.
What the Blue Cross Plans Alleged
Beyond Anthem, three other Blue Cross Blue Shield plans filed similar lawsuits against HaloMD. Together, the four suits painted a picture of systematic gaming of the arbitration process for financial gain.
A Costly Side Effect
The plaintiffs argued that the No Surprises Act unintentionally created a profitable loophole. Because arbitrators must weigh the median in-network rate when deciding cases, a well-represented provider can often secure awards that exceed what they would have received through standard contracting. HaloMD, the insurers alleged, built its business model around this dynamic.
The California dismissal does not resolve the remaining three lawsuits. Those cases remain pending, and their outcomes could shape how courts interpret arbitration eligibility under the No Surprises Act.
Implications for Insurers and Providers
This ruling carries implications well beyond HaloMD and Anthem. It touches on a fundamental tension in the No Surprises Act: the law was written to protect patients, but it also created an arbitration system that both sides can use strategically.
Insurers face growing financial pressure as arbitration volumes rise. Each case that goes to arbitration and results in a higher payment increases costs that ultimately flow through to premiums. Providers, meanwhile, argue that arbitration gives them a fair mechanism to challenge inadequate insurer payment offers.
The California ruling suggests that courts will not easily side with insurers seeking to void arbitration outcomes. To succeed, a plaintiff must show a clear legal basis — not simply that the outcomes were unfavorable.
What Comes Next
The dismissal of the California lawsuit is a win for HaloMD, but the legal battle continues. Three Blue Cross Blue Shield cases remain active. Regulators and policymakers are also watching the No Surprises Act arbitration system closely, with concerns about unsustainable claim volumes putting strain on the process.
For healthcare providers, middlemen, and insurers, the outcome of the remaining cases will determine whether the arbitration channel remains open as a high-volume dispute resolution tool — or whether courts begin to impose tighter limits on who can use it and how.
